Development of [18F]ICMT-11 for Imaging Caspase-3/7 Activity during Therapy-Induced Apoptosis.

No Thumbnail Available

Date

2020-08-06

Authors

García-Argüello, Segundo Francisco
Lopez-Lorenzo, Beatriz
Cornelissen, Bart
Smith, Graham

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Insufficient apoptosis is a recognised hallmark of cancer. A strategy to quantitatively measure apoptosis in vivo would be of immense value in both drug discovery and routine patient management. The first irreversible step in the apoptosis cascade is activation of the "executioner" caspase-3 enzyme to commence cleavage of key structural proteins. One strategy to measure caspase-3 activity is Positron Emission Tomography using isatin-5-sulfonamide radiotracers. One such radiotracer is [18F]ICMT-11, which has progressed to clinical application. This review summarises the design and development process for [18F]ICMT-11, suggesting potential avenues for further innovation.

Description

MeSH Terms

DeCS Terms

CIE Terms

Keywords

Michael acceptor, [18F]ICMT-11, apoptosis, caspase-3, positron emission tomography, pyrimidoindolone

Citation